CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Ticker SymbolCBLL
Company nameCeriBell Inc
IPO dateOct 11, 2024
Founded at2014
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Number of employees281
Security typeOrdinary Share
Fiscal year-endOct 11
Address360 N. Pastoria Avenue
CitySUNNYVALE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94085
Phone18004360826
Websitehttps://ceribell.com/
Ticker SymbolCBLL
IPO dateOct 11, 2024
Founded at2014
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data